Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$7.06 - $23.63 $2.04 Million - $6.83 Million
-288,964 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$21.6 - $27.79 $2.97 Million - $3.83 Million
137,666 Added 90.99%
288,964 $5.27 Million
Q4 2021

Feb 11, 2022

BUY
$23.0 - $29.01 $457,746 - $577,357
19,902 Added 15.15%
151,298 $4.18 Million
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $254,581 - $305,620
-10,167 Reduced 7.18%
131,396 $3.66 Million
Q2 2021

Aug 16, 2021

SELL
$27.43 - $32.7 $687,752 - $819,887
-25,073 Reduced 15.05%
141,563 $4.15 Million
Q1 2021

May 13, 2021

BUY
$21.37 - $34.38 $682,579 - $1.1 Million
31,941 Added 23.71%
166,636 $5.29 Million
Q4 2020

Feb 17, 2021

SELL
$15.31 - $21.12 $691,537 - $953,969
-45,169 Reduced 25.11%
134,695 $2.8 Million
Q3 2020

Nov 13, 2020

BUY
$14.88 - $20.13 $783,179 - $1.06 Million
52,633 Added 41.37%
179,864 $2.8 Million
Q2 2020

Aug 13, 2020

BUY
$13.31 - $20.51 $428,448 - $660,216
32,190 Added 33.87%
127,231 $2.33 Million
Q1 2020

May 13, 2020

SELL
$12.98 - $30.25 $2.24 Million - $5.22 Million
-172,699 Reduced 64.5%
95,041 $1.47 Million
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $5.06 Million - $8.54 Million
267,740 New
267,740 $8.01 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.